Long-term prognostic implications of CT angiography-derived fractional flow reserve: Results from the DISCOVER-FLOW study.

Coronary CT angiography Fractional flow reserve Long-term outcome Non-invasive imaging Risk stratification

Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
19 Feb 2024
Historique:
received: 05 11 2023
revised: 08 01 2024
accepted: 26 01 2024
medline: 21 2 2024
pubmed: 21 2 2024
entrez: 20 2 2024
Statut: aheadofprint

Résumé

The long-term prognostic implications of CT angiography-derived fractional flow reserve (FFR A total of 156 vessels from 102 patients with stable coronary artery disease, who underwent coronary CT angiography (CCTA) and invasive FFR measurement, were followed. The primary endpoint was target vessel failure (TVF), including cardiovascular death, target vessel myocardial infarction, and target vessel revascularization. Outcome analysis with FFR During median 9.9 years of follow-up, TVF occurred in 20 (12.8%) vessels. FFR FFR NCT01189331.

Sections du résumé

BACKGROUND & OBJECTIVES OBJECTIVE
The long-term prognostic implications of CT angiography-derived fractional flow reserve (FFR
MATERIALS & METHODS METHODS
A total of 156 vessels from 102 patients with stable coronary artery disease, who underwent coronary CT angiography (CCTA) and invasive FFR measurement, were followed. The primary endpoint was target vessel failure (TVF), including cardiovascular death, target vessel myocardial infarction, and target vessel revascularization. Outcome analysis with FFR
RESULTS RESULTS
During median 9.9 years of follow-up, TVF occurred in 20 (12.8%) vessels. FFR
CONCLUSION CONCLUSIONS
FFR
CLINICAL TRIAL REGISTRATION BACKGROUND
NCT01189331.

Identifiants

pubmed: 38378313
pii: S1934-5925(24)00027-3
doi: 10.1016/j.jcct.2024.01.016
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01189331']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interest: BKK received research grants from Abbott, Philips, and HeartFlow, provided to the Seoul National University. JL holds stock options in and serves as a consultant to HeartFlow and Circle CVI, and has a research grant from GE Healthcare. GC, MS, CZ, and CAT are the employees and shareholders of HeartFlow, Inc.

Auteurs

Seokhun Yang (S)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Jaewook Chung (J)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Krista Lesina (K)

Department of Medicine, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Joon-Hyung Doh (JH)

Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.

Sanda Jegere (S)

Department of Medicine, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Andrejs Erglis (A)

Department of Medicine, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Jonathon A Leipsic (JA)

Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

William F Fearon (WF)

Division of Cardiology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.

Jagat Narula (J)

The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.

Bon-Kwon Koo (BK)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea. Electronic address: bkkoo@snu.ac.kr.

Classifications MeSH